Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Covington
Cantor Fitzgerald
Express Scripts
Julphar
Accenture
US Army
Boehringer Ingelheim
AstraZeneca

Generated: April 21, 2018

DrugPatentWatch Database Preview

TRUSOPT Drug Profile

« Back to Dashboard

When do Trusopt patents expire, and when can generic versions of Trusopt launch?

Trusopt is a drug marketed by Merck and is included in one NDA.

The generic ingredient in TRUSOPT is dorzolamide hydrochloride. There are fourteen drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the dorzolamide hydrochloride profile page.
Summary for TRUSOPT
Drug patent expirations by year for TRUSOPT
Pharmacology for TRUSOPT
Synonyms for TRUSOPT
(4S,6S)-4-(Ethylamino)-5,6-dihydro-6-methyl-4H-thieno(2,3-b)thiopyran-2-sulfonamide 7,7-dioxide, monohydrochloride
(4S,6S)-4-(ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide hydrochloride
(4S,6S)-4-(ethylamino)-6-methyl-7,7-dioxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide hydrochloride
(4S,6S)-4-(ethylamino)-6-methyl-7,7-dioxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide;hydrochloride
130693-82-2
279D961
4H-Thieno(2,3-b)thiopyran-2-sulfonamide, 4-(ethylamino)-5,6-dihydro-6-methyl-, 7,7-dioxide, monohydrochloride, (4S-trans)-
4H-Thieno(2,3-b)thiopyran-2-sulfonamide, 5,6-dihydro-4-(ethylamino)-6-methyl-, 7,7-dioxide, monohydrochloride, (4S,6S)-
ABP001060
AC-5244
AC1OCF25
AK323617
AKOS005146235
AKOS015895951
API0007146
BC208520
Bio-0123
C10H16N2O4S3.HCl
CAS-130693-82-2
CC-27373
CCG-221116
CHEBI:4703
CHEMBL1201162
Cosopt
CS-1858
CTK8E7974
D00653
D4189
Dorzolamide (hydrochloride)
Dorzolamide for system suitability, European Pharmacopoeia (EP) Reference Standard
Dorzolamide HCl
Dorzolamide HCl salt
DORZOLAMIDE HYDROCHLORIDE
Dorzolamide hydrochloride (JP17/USP)
Dorzolamide hydrochloride [USAN:USP]
Dorzolamide hydrochloride, European Pharmacopoeia (EP) Reference Standard
Dorzolamide hydrochloride, United States Pharmacopeia (USP) Reference Standard
Dorzolomide hydrochloride
DSSTox_CID_25530
DSSTox_GSID_45530
DSSTox_RID_80933
DTXSID1045530
FT-0082547
FT-0631133
HMS1571O14
HY-B0109A
I06-1271
J10249
K-4065
KB-50425
KS-00000XJI
KS-1348
L 671152
L-671,152
L-671152
MK 0507
MK-0507
MK-507
MLS002154162
MolPort-005-935-141
NCGC00016977-01
NCGC00179244-03
OSRUSFPMRGDLAG-QMGYSKNISA-N
QZO5366EW7
RTC-070963
s1375
SC-18010
SCHEMBL41152
SMR001233461
TC-070963
Tox21_110720
Tox21_110720_1
UNII-QZO5366EW7

US Patents and Regulatory Information for TRUSOPT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck TRUSOPT dorzolamide hydrochloride SOLUTION/DROPS;OPHTHALMIC 020408-001 Dec 9, 1994 AT RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for TRUSOPT

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck TRUSOPT dorzolamide hydrochloride SOLUTION/DROPS;OPHTHALMIC 020408-001 Dec 9, 1994 ➤ Try a Free Trial ➤ Try a Free Trial
Merck TRUSOPT dorzolamide hydrochloride SOLUTION/DROPS;OPHTHALMIC 020408-001 Dec 9, 1994 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for TRUSOPT
Drugname Dosage Strength RLD Submissiondate
➤ Subscribe Ophthalmic Solution 2% ➤ Subscribe 2005-10-11

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Chubb
McKinsey
Farmers Insurance
Queensland Health
Dow
US Army
Express Scripts
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.